T1	p 115 146	rheumatoid arthritis patients .
T2	p 395 434	patients with rheumatoid arthritis ( RA
T3	p 481 494	RA patients '
T4	p 594 610	The participants
T5	p 616 624	the GT3X
T6	p 1016 1064	Sixty-eight RA patients ( age=55?13 years , body
T7	p 1070 1075	index
T8	p 1105 1112	disease
T9	p 1126 1154	2-8 ) yrs ) were recruited .
T10	p 1564 1575	VO2max with
T11	p 1657 1659	PA
T12	p 1840 1842	PA
T13	p 2125 2127	RA
T14	p 2166 2175	sedentary
T15	p 2457 2475	people with RA and
T16	p 2611 2629	5 September 2012 .
T17	i 298 318	Questionnaire ; IPAQ
T18	i 369 382	activity ( PA
T19	i 1399 1409	light PA (
T20	i 1625 1627	PA
T21	i 1700 1706	PA , (
T22	i 1712 1713	)
T23	i 1817 1830	IPAQ-reported
T24	i 1840 1846	PA and
T25	i 2409 2411	PA
T26	i 2416 2418	ST
T27	o 21 58	objective levels of physical activity
T28	o 86 103	cardiorespiratory
T29	o 218 227	agreement
T30	o 236 246	subjective
T31	o 280 318	Physical Activity Questionnaire ; IPAQ
T32	o 360 391	physical activity ( PA ) levels
T33	o 495 509	subjective and
T34	o 542 572	the maximal oxygen uptake test
T35	o 689 706	Bland-Altman plot
T36	o 770 788	subjective PA data
T37	o 799 807	Wilcoxon
T38	o 883 885	PA
T39	o 902 908	VO2max
T40	o 995 997	's
T41	o 1060 1075	body mass index
T42	o 1237 1239	PA
T43	o 1275 1285	. Wilcoxon
T44	o 1329 1347	time spent engaged
T45	o 1351 1371	sedentary behaviours
T46	o 1399 1407	light PA
T47	o 1440 1451	moderate PA
T48	o 1580 1597	PA levels derived
T49	o 1619 1635	light PA rho=.35
T50	o 1657 1659	PA
T51	o 1700 1702	PA
T52	o 1764 1785	sedentary time ( ST )
T53	o 2003 2032	IPAQ-VO2 max and GT3X-VO2 max
T54	o 2059 2061	ST
T55	o 2196 2215	higher intensity PA
T56	o 2253 2266	Accelerometry
T57	o 2302 2313	PA levels .
T58	o 2319 2329	subjective
T59	o 2339 2342	and
T60	o 2395 2415	self-reported PA and